BCL9L and glioma: In addition, silencing BCL9L impaired glioma cell proliferation, whereas overexpressing BCL9L strengthened it, both in vitro (Figure 2D and Supplementary Figure 1E) and in vivo (Figure 2E and Supplementary Figure 1F).